Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

The medication segment was the largest in 2022, favored for its cost-effectiveness and common use as a first-line treatment. .Centriacinar Emphysema Growth: The centriacinar segment, primarily linked ...

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

Our scans show where there is patchy ventilation in patients with lung disease, and show us which parts of the lung improve ...

For the past 10 years, medications and inhalers began to help less and less with Rose Walsh’s breathing problems. Battling ...

New Study Shows Promising Results for COPD Treatment Nov. 20 ... The results of the study, which used organoids derived from embryonic lungs, open up new perspectives ... Nov. 27, 2024 ...

Stapokibart (Kangyueda) is a humanized monoclonal antibody. It is formulated as a solution for the subcutaneous route of administration. Kangyueda is indicated for the treatment of moderate to severe ...

APG-808 is under clinical development by Apogee Therapeutics and currently in Phase I for Unspecified Immunological Disorders.

Hunter recommends seeking medical help if you suspect HMPV and have symptoms like a high fever (over 103F/40C), difficulty ...

Smoking steals life expectancy, increases health risks, and impacts overall well-being, but quitting can lead to significant improvements.

The recent surge in Human Metapneumovirus (HMPV) cases in China has triggered global attention, prompting the Indian health ...

has been approved since 2020 in the US as a maintenance treatment used to reduce exacerbations in people living with chronic obstructive pulmonary disease (COPD). Sales of Breztri were $677 ...